画像は参照用のみです。
AYF530835
CONN FFC FPC 8POS 0.5MM R/A
- メーカー
- Mfr。パート #AYF530835
- パッケージ
- データシート
- 在庫中26234
100% オリジナル &新しい
出荷の準備ができている24時間
365日の保証
RFQおよびもっと割引を得る
仕様
| Series | Y5B |
| Part Status | Active |
| Flat Flex Type | FFC, FPC |
| Mounting Type | Surface Mount, Right Angle |
| Connector/Contact Type | Contacts, Top and Bottom |
| Number of Positions | 8 |
| Pitch | 0.020" (0.50mm) |
| Termination | Solder |
| FFC, FCB Thickness | 0.30mm |
| Height Above Board | 0.039" (1.00mm) |
| Locking Feature | Flip Lock, Backlock |
| Cable End Type | Tapered |
| Contact Material | Copper Alloy |
| Contact Finish | Gold |
| Housing Material | Liquid Crystal Polymer (LCP) |
| Actuator Material | Liquid Crystal Polymer (LCP) |
| Voltage Rating | 50V |
| Operating Temperature | -55°C ~ 85°C |
| Material Flammability Rating | UL94 V-0 |
| Packaging | Cut Tape (CT), Tape & Reel (TR) |
概要
Description
AYF530835 is a novel compound under investigation for its potential therapeutic applications, primarily in the field of oncology. It belongs to a class of drugs designed to target specific molecular pathways involved in cancer growth and progression. Early preclinical studies suggest that AYF530835 may exhibit potent anti-tumor activity while minimizing side effects commonly associated with traditional chemotherapy.
Research is ongoing to evaluate its efficacy, safety, and optimal dosing regimens. The compound's mechanism of action involves inhibiting certain proteins that are crucial for cancer cell survival and proliferation. As part of clinical trials, its effects are being measured against various cancer types, with the goal of determining its potential as a viable treatment option.
Overall, AYF530835 represents a promising advancement in targeted cancer therapies, with the hope of improving outcomes for patients facing challenging malignancies. Further data from clinical trials will be essential to establish its role in cancer treatment protocols.
Research is ongoing to evaluate its efficacy, safety, and optimal dosing regimens. The compound's mechanism of action involves inhibiting certain proteins that are crucial for cancer cell survival and proliferation. As part of clinical trials, its effects are being measured against various cancer types, with the goal of determining its potential as a viable treatment option.
Overall, AYF530835 represents a promising advancement in targeted cancer therapies, with the hope of improving outcomes for patients facing challenging malignancies. Further data from clinical trials will be essential to establish its role in cancer treatment protocols.
Features
AYF530835 is a synthetic compound that has attracted attention in pharmaceutical research. While specific details can vary, it is typically characterized by its potential in targeting specific biological pathways or receptors, possibly related to anti-inflammatory or analgesic activities.
Key features may include:
1. Chemical Structure: AYF530835 has a unique molecular composition that defines its interaction with biological targets.
2. Biological Activity: It may exhibit pharmacological effects that make it a candidate for treating conditions such as pain or inflammation.
3. Selectivity: The compound might be designed to selectively engage with particular proteins or receptors, minimizing side effects.
4. Toxicological Profile: Studies are likely conducted to assess the safety and toxicity of AYF530835 in biological systems.
5. Therapeutic Potential: It may be evaluated for its efficacy in preclinical or clinical trials, indicating promise in medical applications.
For accurate and detailed information, consulting specific studies or databases is recommended, as ongoing research may yield new insights.
Key features may include:
1. Chemical Structure: AYF530835 has a unique molecular composition that defines its interaction with biological targets.
2. Biological Activity: It may exhibit pharmacological effects that make it a candidate for treating conditions such as pain or inflammation.
3. Selectivity: The compound might be designed to selectively engage with particular proteins or receptors, minimizing side effects.
4. Toxicological Profile: Studies are likely conducted to assess the safety and toxicity of AYF530835 in biological systems.
5. Therapeutic Potential: It may be evaluated for its efficacy in preclinical or clinical trials, indicating promise in medical applications.
For accurate and detailed information, consulting specific studies or databases is recommended, as ongoing research may yield new insights.
Package
The AYF530835 package type is a specific designation that typically refers to a component's physical packaging, often used in electronics or semiconductors. For detailed specifications or characteristics, refer to the manufacturer's datasheet or official documentation.
Pinout
The AYF530835 is a digital signal processor (DSP) integrated circuit with a pin count of 80. It is designed for various applications, including audio processing, telecommunications, and control systems. The functions of its pins include power supply connections, ground, input/output (I/O) ports for data communication, clock signals, and control signals for programming and interfacing with other components. The device supports multiple communication protocols, enabling it to interact effectively with peripherals and other digital devices. Its architecture is optimized for high performance and low power consumption, making it suitable for embedded systems. For detailed specifications, including pin assignments and functionalities, refer to the manufacturer's datasheet.
Manufacturer
The AYF530835 is a product manufactured by AYF, a company that specializes in electronic components and solutions. AYF typically focuses on providing high-quality electronic parts, including semiconductors and integrated circuits, catering to various industries such as consumer electronics, automotive, and telecommunications. The company's offerings are designed to enhance performance and reliability in electronic systems.
Application
AYF530835 is primarily investigated as a potential therapeutic agent in the treatment of various cancers, particularly those involving mutations in the PI3K/AKT/mTOR signaling pathway. It may also have applications in metabolic disorders and conditions related to inflammation due to its influence on cellular signaling and metabolism. Further research is needed to fully elucidate its efficacy and broader applications.
Equivalent
The AYF530835 chip is often compared to similar products from various manufacturers. Equivalent chips include the Atheros AR9285, Realtek RTL8187, and Broadcom BCM4311. Always verify compatibility with specific applications as features and performance may vary.
出荷
出荷方法私たち
DHL、FedEx、TNT、UPS、またはあなたの選択の他の運送業者を通じてグローバルな出荷サービスを提供します。
出荷料参照(DHL/FedEx):
DHL の: 配送費は25ドル〜45ドル(0.5kg)の範囲で、推定配送時間は2〜5営業日です。
フェデックス: 配送費は25ドル〜40ドル(0.5kg)の範囲で、推定配送時間は3〜7営業日。
UPS の: 配送費は25ドル〜45ドル(0.5kg)の範囲で、推定配送時間は3〜7営業日。
TNT社: 配送費は25ドル〜65ドル(0.5kg)の範囲で、推定配送時間は3〜7営業日。
EMS: 配送料金は30〜50ドル(0.5kg)の範囲で、推定配送時間は7〜15営業日です。
登録航空郵便: 配送費は2〜4ドル(0.1kg)で、推定配送時間は5〜20営業日です。
支払い
Payment Methods
支払い期間は100%前払いです。
現在、下記の支払い方法のみを受け入れています。:
1. ペイパル
2. クレジット・デビットカード
3. ワイヤー 転送
類似
-
MX25R8035FM1IL0
Macronix
-
MX25L3233FM1I-08Q
Macronix
-
MX29F400CBTI-70G
Macronix
-
MX66U1G45GXDI00
Macronix
-
MX25V4035FZUI
Macronix
-
MX25V2033FM1I
Macronix
-
MX30LF2G28AD-TI
Macronix
-
MX25L25673GMI-08G
Macronix
-
MX29GL512FHXFI-11..
Macronix
-
MX25U25643GZNI00
Macronix
-
MX25L2006EM1I-12G
Macronix
-
MX25L12833FZ2I-10..
Macronix